Publications of Institute of Radiooncology - OncoRay (from 2013)

177 Publications
FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy
Zschaeck, S.; Löck, S.; Leger, S.; Haase, R.; Bandurska-Luque, A.; Appold, S.; Kotzerke, J.; Zips, D.; Richter, C.; Gudziol, V.; Schreiber, A.; Zöphel, K.; Baumann, M.; Krause, M.

Individualized early death and long-term survival prediction after stereotactic radiosurgery for brain metastases of non-small cell lung cancer: Two externally validated nomograms
Zindler, J.; Jochems, A.; Lagerwaard, F.; Beumer, R.; Troost, E.; Eekers, D.; Compter, I.; van der Toorn, P.-P.; Essers, M.; Oei, B.

Comparison of toxicity and outcome in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy using IMRT or VMAT
Wijsman, R.; Dankers, F.; Troost, E. G. C.; Hoffmann, A. L.; van der Heijden, E. H. F. M.; de Geus-Oei, L. F.; Bussink, J.

Low CSC marker expression and low hypoxia identify good prognosis subgroups in HPV(-)HNSCC after postoperative radiochemotherapy: a multicenter study of the DKTK-ROG
Linge, A.; Löck, S.; Gudziol, V.; Nowak, A.; Lohaus, F.; von Neubeck, C.; Jütz, M.; Abdollahi, A.; Debus, J.; Tinhofer, I.; Budach, V.; Sak, A.; Stuschke, M.; Balermpas, P.; Rödel, C.; Avlar, M.; Grosu, A. L.; Bayer, C.; Belka, C.; Pigorsch, S.; Combs, S. E.; Welz, S.; Zips, D.; Buchholz, F.; Aust, D. E.; Baretton, G. B.; Thames, H. D.; Dubrovska, A.; Alsner, J.; Overgaard, J.; Baumann, M.; Krause, M.; DKTK-RTOG

3D matrix-based cell cultures: Automated analysis of tumor cell survival and proliferation
Eke, I.; Hehlgans, S.; Sandfort, V.; Cordes, N.
  • International Journal of Oncology 48(2016)1, 313-321

Ambidextrous Idea Generation-Antecedents and Outcomes
Gurtner, S.; Reinhardt, R.

Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation
Tinhofer, I.; Budach, V.; Saki, M.; Konschak, R.; Niehr, F.; Jöhrens, K.; Weichert, W.; Linge, A.; Lohaus, F.; Krause, M.; Neumann, K.; Endris, V.; Sak, A.; Stuschke, M.; Balermpas, P.; Rödel, C.; Avlar, M.; Grosu, A. L.; Abdollahi, A.; Debus, J.; Belka, C.; Pigorsch, S.; Combs, S. E.; Mönnich, D.; Zips, D.; Baumann, M.; DKTK-ROG

A Compton camera prototype for prompt gamma medical imaging
Thirolf, P. G.; Aldawood, S.; Böhmer, M.; Bortfeldt, J.; Castelhano, I.; Dedes, G.; Fiedler, F.; Gernhäuser, R.; Golnik, C.; Helmbrecht, S.; Hueso-González, F.; von D. Kolff, H.; Kormoll, T.; Lang, C.; Liprandi, S.; Lutter, R.; Marinšek, T.; Maier, L.; Pausch, G.; Petzoldt, J.; Römer, K.; Schaart, D.; Parodi, K.

The impact of CDK9 on radiosensitivity, DNA damage repair and cell cycling of HNSCC cancer cells
Storch, K.; Cordes, N.

ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1.
Offersen, B. V.; Boersma, L. J.; Kirkove, C.; Hol, S.; Aznar, M. C.; Sola, A. B.; Kirova, Y. M.; Pignol, J.-P.; Remouchamps, V.; Verhoeven, K.; Weltens, C.; Arenas, M.; Gabrys, D.; Kopek, N.; Krause, M.; Lundstedt, D.; Marinko, T.; Montero, A.; Yarnold, J.; Poortmans, P.

Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy
Linge, A.; Löck, S.; Krenn, C.; Appold, S.; Lohaus, F.; Nowak, A.; Gudziol, V.; Baretton, G. B.; Buchholz, F.; Baumann, M.; Krause, M.

Clinical trials for personalized glioblastoma radiotherapy: Markers for efficacy and late toxicity but often delayed treatment – Does that matter?
Lattermann, A.; Baumann, M.; Krause, M.

Targeting of β1 integrins impairs DNA repair for radiosensitization of head and neck cancer cells
Dickreuter, E.; Eke, I.; Krause, M.; Borgmann, K.; van Vugt, M. A.; Cordes, N.

Bridging the valley of death: The new Radiotherapy & Oncology section “First in man - Translational innovations in radiation oncology.”
Baumann, M.; Overgaard, J.

Polyphenols delivery by polymeric materials: challenges in cancer treatment.
Vittorio, O.; Curcio, M.; Cojoc, M; Goya, G.; Hampel, S.; Iemma, F.; Dubrovska, A; Cirillo, G.

Nanoparticles for radiooncology: Mission, vision, challenges.
L Kunz-Schughart ; A Dubrovska; C Peitzsch ; Ewe, A.; Aigner, A.; Schellenburg, S.; Muders, M.; Hampel, S.; Cirillo, G.; Iemmae, F.; Tietze, R.; Alexiou, C.; Stephan, H.; Zarschlerg, K.; Vittorio, O.; Kavallaris, M.; Parak, W.; Mädler, L.; Pokhrel, S.

Nanoparticles for radiooncology: Mission, vision, challenges
Kunz-Schughart, L. A.; Dubrovska, A.; Peitzsch, C.; Ewe, A.; Aigner, A.; Schellenburg, S.; Muders, M. H.; Hampel, S.; Cirillo, G.; Iemma, F.; Tietze, R.; Alexiou, C.; Stephan, H.ORC; Zarschler, K.; Vittorio, O.; Kavallaris, M.; Parak, W. J.; Mädler, L.; Pokhrel, S.

Toward Distributed Conduction of Large-Scale Studies in Radiation Therapy and Oncology: Open-Source System Integration Approach
Skripcak, T.; Just, U.; Simon, M.; Buttner, D.; Lühr, A.; Baumann, M.; Krause, M.

Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG.
Linge, A.; Löck, S.; Gudziol, V.; Nowak, A.; Lohaus, F.; von Neubeck, C.; Jütz, M.; Abdollahi, A.; Debus, J.; Tinhofer, I.; Budach, V.; Sak, A.; Stuschke, M.; Balermpas, P.; Rödel, C.; Avlar, M.; Grosu, A. L.; Bayer, C.; Belka, C.; Pigorsch, S.; Combs, S. E.; Welz, S.; Zips, D.; Buchholz, F.; Aust, D. E.; Baretton, G. B.; Thames, H. D.; Dubrovska, A.; Alsner, J.; Overgaard, J.; Baumann, M.; Krause, M.

Correlation of FMISO simulations with pimonidazole-stained tumor xenografts: A question of O2 consumption?
Wack, L. J.; Mönnich, D.; Yaromina, A.; Zips, D.; Baumann, M.; Thorwarth, D.

Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer
Zegers, C. M. L.; Hoebers, F. J. P.; van Elmpt, W.; Bons, J. A.; Öllers, M. C.; Troost, E. G. C.; Eekers, D.; Balmaekers, L.; Arts-Pechtold, M.; Mottaghy, F. M.; Lambin, P.

Impact of pre- and early per-treatment FDG-PET based dose-escalation on local tumour control in fractionated irradiated FaDu xenograft tumours.
Jentsch, C.; Bergmann, R.; Brüchner, K.; Mosch, B.; Yaromina, A.; Krause, M.; Zips, D.; Troost, E. G. C.; Löck, S.; Kotzerke, J.; Steinbach, J.; Thames, H.; Baumann, M.; Beuthien-Baumann, B.

HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Linge, A.; Lohaus, F.; Löck, S.; Nowak, A.; Gudziol, V.; Valentini, C.; von Neubeck, C.; Jütz, M.; Tinhofer, I.; Budach, V.; Sak, A.; Stuschke, M.; Balermpas, P.; Rödel, C.; Grosu, A. L.; Abdollahi, A.; Debus, J.; Ganswindt, U.; Belka, C.; Pigorsch, S.; Combs, S. E.; Mönnich, D.; Zips, D.; Buchholz, F.; Aust, D. E.; Baretton, G. B.; Thames, H. D.; Dubrovska, A.; Alsner, J.; Overgaard, J.; Krause, M.; Baumann, M.

Internal and external validation of an ESTRO delineation guideline - dependent automated segmentation tool for loco-regional radiation therapy of early breast cancer.
Eldesoky, A. R.; Yates, E. S.; Nyeng, T. B.; Thomsen, M. S.; Nielsen, H. M.; Poortmans, P.; Kirkove, C.; Krause, M.; Kamby, C.; Mjaaland, I.; Blix, E. S.; Jensen, I.; Berg, M.; Lorenzen, E. L.; Taheri-Kadkhoda, Z.; Offersen, B. V.

The Clinical Target Volume in Lung, Head-and-neck, and Esophageal Cancer: Lessons from Pathological Measurement and Recurrence Analysis
Apolle, R.ORC; Rehm, M.; Bortfeld, T.; Baumann, M.; Troost, E.

Vertebral fractures – An underestimated side-effect in patients treated with radio(chemo)therapy
Pilz, K.; Hoffmann, A. L.; Baumann, M.; Troost, E. G. C.

Technical feasibility of integrating 7 T anatomical MRI in image‑guided radiotherapy of glioblastoma: a preparatory study
Compter, I.; Peerlings, J.; Eekers, D. B. P.; Postma, A. A.; Ivanov, D.; Wiggins, C. J.; Kubben, P.; Küsters, B.; Wesseling, P.; Ackermans, L.; Schijns, O. E. M. G.; Lambin, P.; Hoffmann, A. L.

Radiation oncology in the era of precision medicine
Baumann, M.; Krause, M.; Overgaard, J.; Debus, J.; Bentzen, S. M.; Daartz, J.; Richter, C.; Zips, D.; Bortfeld, T.

PRONTOX - proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial
Zschaeck, S.; Simon, M.; Löck, S.; Troost, E. G. C.; Stützer, K.; Wohlfahrt, P.; Appold, S.; Makocki, S.; Bütof, R.; Richter, C.; Baumann, M.; Krause, M.

Evaluation of a deformable registration algorithm for subsequent lung computed tomography imaging during radiochemotherapy
Stützer, K.; Haase, R.; Lohaus, F.; Barczyk, S.; Exner, F.; Löck, S.; Rühaak, J.; Lassen-Schmidt, B.; Corr, D.; Richter, C.

The Why and How of Amino Acid Analytics in Cancer Diagnostics and Therapy
Manig, F.; Kuhne, K.; von Neubeck, C.; Schwarzenbolz, U.; Yu, Z.; Kessler, B. M.; Pietzsch, J.; Kunz-Schughart, L. A.

Methodological accuracy of image-based electron-density assessment using dual-energy computed tomography
Möhler, C.ORC; Wohlfahrt, P.ORC; Richter, C.; Greilich, S.

The controversial role of phospholipase C epsilon (PLCε) in cancer development and progression
Tyutyunnykova, A.; Telegeev, G.; Dubrovska, A.
Corresponding author: Dubrovska, Anna HZDR, OncoRay, TU Dresden

Cancer stem cells: the root of tumor recurrence and metastases
Peitzsch, C.; Tyutyunnykova, A.; Pantel, K.; Dubrovska, A.

Is selective nodal irradiation in non-small cell lung cancer still safe when using IMRT? Results of a prospective cohort study.
Martinussen, H. M. A.; Reymen, B.; Wanders, R.; Troost, E. G. C.; Dingemans, A.-M. C.; Öllers, M.; Houben, R.; de Ruysscher, D.; Lambin, P.; van Baardwijk, A.

Digital high-pass filter deconvolution by means of an infinite impulse response filter
Födisch, P.; Wohsmann, J.; Lange, B.; Schönherr, J.; Enghardt, W.; Kaever, P.

Charge-sensitive front-end electronics with operational amplifiers for CdZnTe detectors
Födisch, P.; Berthel, M.; Lange, B.; Kirschke, T.; Enghardt, W.; Kaever, P.

Resistive switching behavior in single crystal SrTiO3 annealed by laser
Pan, X.; Shuai, Y.; Wu, C.; Luo, W.; Sun, X.; Yuan, Y.; Zhou, S.; Ou, X.; Zhang, W.

Who will benefit most from hydrogel rectum spacer implantation in prostate cancer radiotherapy? A model-based approach for patient selection
Vanneste, B. G. L.; Hoffmann, A. L.; van Lin, E. N.; van de Voorde, L.; Pinkawa, M.; Lambin, P.

[18F]FDG-PET/CT based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches
de Jong, E.; van Elmpt, W.; Leijenaar, R.; Hoekstra, O.; Groen, H.; Smit, E.; Boellaard, R.; van der Noort, V.; Troost, E.; Lambin, P.; Dingemans, A.

Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicentric in silico ROCOCO trial
Eekers, D. B. P.; Roelofs, E.; Jelen, U.; Kirk, M.; Granzier, M.; Ammazzalorso, F.; Ahn, P. H.; Janssens, G. O. R. J.; Hoebers, F. J. P.; Friedmann, T.; Solberg, T.; Walsh, S.; Troost, E. G. C.; Kaanders, J. H. A. M.; Lambin, P.

Clinical implementation of dual-energy CT for proton treatment planning on pseudo-monoenergetic CT scans
Wohlfahrt, P.; Möhler, C.; Hietschold, V.; Menkel, S.; Greilich, S.; Krause, M.; Baumann, M.; Enghardt, W.; Richter, C.

Range prediction for tissue mixtures based on dual-energy CT
Möhler, C.; Wohlfahrt, P.; Richter, C.; Greilich, S.

The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC 3 prostate cancer in vitro and in vivo
Liebscher, S.; Koi, L.; Löck, S.; Muders, M. H.; Krause, M.
Corresponding author: Liebscher, Steffi
Corresponding author: Koi, Lydia
Corresponding author: Löck, Steffen
Corresponding author: Muders, M. H.
Corresponding author: Krause, Mechthild
  • Clinical and Translational Radiation Oncology (2017)

BEMER electromagnetic field therapy reduces cancer cell radioresistance by enhanced ROS formation and induced DNA damage
Storch, K.; Dickreuter, E.; Artati, A.; Adamski, J.; Cordes, N.
Corresponding author: Cordes, N.

Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent chemoradiotherapy.
Wink, K. C. J.; Belderbos, J. S. A.; Dieleman, E. M. T.; Rossi, M.; Rasch, C. R. N.; Damhuis, R. A. M.; Houben, R. M. A.; Troost, E. G. C.

An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells.
Peitzsch, C.; Cojoc, M.; Hein, L.; Kurth, I.; Mäbert, K.; Trautmann, F.; Klink, B.; Schröck, E.; Wirth, M. P.; Krause, M.; Stakhovsky, E. A.; Telegeev, G. D.; Novotny, V.; Toma, M.; Muders, M.; Baretton, G. B.; Frame, F. M.; Maitland, N. J.; Baumann, M.; Dubrovska, A.

[Melanoma brain metastases : Treatment options]. [Hirnmetastasen des malignen Melanoms].
Rauschenberg, R.; Tabatabai, G.; Troost, E. G. C.; Garzarolli, M.; Beissert, S.; Meier, F.

Efficacy of Beta1 Integrin and EGFR Targeting in Sphere-Forming Human Head and Neck Cancer Cells
Zscheppang, K.; Kurth, I.; Wachtel, N.; Dubrovska, A.; Kunz-Schughart, L. A.; Cordes, N.

Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
Tawk, B.; Schwager, C.; Deffaa, O.; Dyckhoff, G.; Warta, R.; Linge, A.; Krause, M.; Weichert, W.; Baumann, M.; Herold-Mende, C.; Debus, J.; Abdollahi, A.

Prognostic value of blood-biomarkers related to hypoxia, inflammation, immune response and tumour load in non-small cell lung cancer - A survival model with external validation.
Carvalho, S.; Troost, E. G. C.; Bons, J.; Menheere, P.; Lambin, P.; Oberije, C.

Precise image-guided irradiation of small animals: a flexible non-profit platform
Tillner, F.; Thute, P.; Löck, S.; Dietrich, A.; Fursov, A.; Haase, R.; Lukas, M.; Rimarzig, B.; Sobiella, M.; Krause, M.; Baumann, M.; Bütof, R.; Enghardt, W.

Design and implementation of a robust and cost-effective double-scattering system at a horizontal proton beamline
Helmbrecht, S.; Baumann, M.; Fiedler, F.; Enghardt, W.; Krause, M.; Lühr, A.

Prediction and compensation of magnetic beam deflection in MR-integrated proton therapy: A method optimized regarding accuracy, versatility and speed
Schellhammer, S. M.; Hoffmann, A. L.

Stakeholder integration in new product development – A systematic analysis of drivers and firm capabilities
Martin, M. V.; Reinhardt, R.; Gurtner, S.

In-beam PET at clinical proton beams with pile-up rejection
Helmbrecht, S.; Enghardt, W.; Fiedler, F.; Iltzsche, M.; Pausch, G.; Tintori, C.; Kormoll, T.

How to catch the generation Y: Identifying consumers of ecological innovations among youngsters
Gurtner, S.; Soyez, K.

Prompt gamma rays detected with a BGO block Compton camera reveal range deviations of therapeutic proton beams
Hueso-González, F.; Pausch, G.; Petzoldt, J.; Römer, K. E.; Enghardt, W.

Wertorientierung im Technologiemanagement von Krankenhäusern
Gurtner, S.; Gurtner, K.
  • mt-medizintechnik 2(2015), 57-60

Emerging Role of MRI for Radiation Treatment Planning in Lung Cancer
Cobben, D. C. P.; de Boer, H. C. J.; Tijssen, R. H.; Rutten, E. G. G. M.; van Vulpen, M.; Peerlings, J.; Troost, E. G. C.; Hoffmann, A. L.; van Lier, A. L. H. M. W.

Magnetic Nanoparticles in tumour xenografts detected and quantified by Micro-Computer Tomography
Bayer, K.; Eckert, H.; Wiekhorst, F.; Trahms, L.; Krause, M.; Odenbach, S.

NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy
Jakobi, A.; Stützer, K.; Bandurska-Luque, A.; Löck, S.; Haase, R.; Wack, L.-J.; Mönnich, D.; Thorwarth, D.; Perez, D.; Lühr, A.; Zips, D.; Krause, M.; Baumann, M.; Perrin, R.; Richter, C.

CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicenter study of the German cancer consortium radiation oncology group (DKTK-ROG)
Balermpas, P.; Rödel, F.; Rödel, C.; Krause, M.; Linge, A.; Lohaus, F.; Baumann, M.; Tinhofer, I.; Budach, V.; Gkika, E.; Stuschke, M.; Avlar, M.; Grosu, A.-L.; Abdollahi, A.; Debus, J.; Bayer, C.; Stangl, S.; Belka, C.; Pigorsch, S.; Multhoff, G.; Combs, S. E.; Mönnich, D.; Zips, D.; Fokas, E.

Increase in tumor control and normal tissue complication probabilities in advanced head-and-neck cancer for dose-escalated intensity-modulated photon and proton therapy
Jakobi, A.; Lühr, A.; Stützer, K.; Bandurska-Luque, A.; Löck, S.; Krause, M.; Baumann, M.; Perrin, R.; Richter, C.
Corresponding author: Krause, M. OncoRay; DKTK partner site Dresden; DKFZ; Strahlentherapie - Universitätsklinikum - Medizinische Fakultät; HZDR

A synchronous Gigabit Ethernet protocol stack for high-throughput UDP/IP applications
Födisch, P.; Lange, B.; Sandmann, J.; Büchner, A.; Enghardt, W.; Kaever, P.

Stereotactic radiotherapy augments the immune response / Die stereotaktische Strahlentherapie unterstützt die Immunantwort
Troost, E. G. C.

Preclinical Assessment of Efficacy of Radiation Dose Painting Based on Intratumoral FDG-PET Uptake.
Trani, D.; Yaromina, A.; Dubois, L.; Granzier, M.; Peeters, S. G.; Biemans, R.; Nalbantov, G.; Lieuwes, N.; Reniers, B.; Troost, E. E.; Verhaegen, F.; Lambin, P.

HPV and beyond-looking out for biomarkers for distinguishing the good prognosis from the bad prognosis group in locally advanced and clinically high risk HNSCC.
Lohaus, F.; Linge, A.; Baumann, M.

Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma.
Kurth, I.; Hein, L.; Mäbert, K.; Peitzsch, C.; Koi, L.; Cojoc, M.; Kunz-Schughart, L.; Baumann, M.; Dubrovska, A.

Global Task Force on Radiotherapy for Cancer Control.
Jaffray, D. A.; Knaul, F. M.; Atun, R.; Adams, C.; Barton, M. B.; Baumann, M.; Lievens, Y.; Lui, T. Y.; Rodin, D. L.; Rosenblatt, E.; Torode, J.; van Dyk, J.; Vikram, B.; Gospodarowicz, M.

Increased evidence for the prognostic value of primary tumor asphericity in pretherapeutic FDG PET for risk stratification in patients with head and neck cancer.
Hofheinz, F.; Lougovski, A.; Zöphel, K.; Hentschel, M.; Steffen, I. G.; Apostolova, I.; Wedel, F.; Buchert, R.; Baumann, M.; Brenner, W.; Kotzerke, J.; van den Hoff, J.

Proton therapy of pediatric rhabdomyosarcoma: Same tumor control as photon therapy, with less adverse effects / Protonentherapie von Rhabdomyosarkompatienten im Kindesalter: Gleiche lokale Tumorkontrolle wie bei Photonentherapie mit weniger Nebenwirkungen
Gurtner, K.; Baumann, M.

Comprehensive analysis of signal transduction in three-dimensional ECM-based tumor cell cultures.
Eke, I.; Hehlgans, S.; Zong, Y.; Cordes, N.

Cell-ECM interactions control DDR
Dickreuter, E.; Cordes, N.
  • Oncoscience 2(2015)8, 679-680

Hyperfractionated accelerated radiation therapy (HART) of 70.6 Gy with concurrent 5-FU/Mitomycin C is superior to HART of 77.6 Gy alone in locally advanced head and neck cancer: long-term results of the ARO 95-06 randomized phase III trial.
Budach, V.; Stromberger, C.; Poettgen, C.; Baumann, M.; Budach, W.; Grabenbauer, G.; Marnitz, S.; Olze, H.; Wernecke, K. D.; Ghadjar, P.

Expanding global access to radiotherapy
Atun, R.; Jaffray, D. A.; Barton, M. B.; Bray, F.; Baumann, M.; Vikram, B.; Hanna, T. P.; Knaul, F. M.; Lievens, Y.; Lui, T. Y.; Milosevic, M.; O'Sullivan, B.; Rodin, D. L.; Rosenblatt, E.; van Dyk, J.; Yap, M. L.; Zubizarreta, E.; Gospodarowicz, M.

Scintillator-Based High-Throughput Fast Timing Spectroscopy for Real-Time Range Verification in Particle Therapy
Pausch, G.; Petzoldt, J.; Berthel, M.; Enghardt, W.; Fiedler, F.; Golnik, C.; Hueso-González, F.; Lentering, R.; Römer, K.; Ruhnau, K.; Stein, J.; Wolf, A.; Kormoll, T.
  • IEEE Transactions on Nuclear Science 63(2016)2, 664-672
  • Lecture (Conference)
    13th International Conference on Scintillators and their Applications (SCINT), 07.-12.06.2015, Berkeley, USA

Approval procedures for clinical trials in the field of radiation oncology
Simon, M.; Habeck, M.; Büttner, D.; Habeck, U.; Nölling, T.; Krause, M.; Brix, G.; Willich, N.; Wenz, F.; Schmidberger, H.; Debus, J.; Baumann, M.

Evaluating the use of optimally respiratory gated 18F-FDG-PET in target volume delineation and its influence on radiation doses to the organs at risk in non-small-cell lung cancer patients
Wijsman, R.; Grootjans, W.; Troost, E. G.; van der Heijden, E. H.; Visser, E. P.; de Geus-Oei, L.-F.; Bussink, J.

First clinical application of a prompt gamma based in vivo proton range verification
Richter, C.; Pausch, G.; Barczyk, S.; Priegnitz, M.; Keitz, I.; Thiele, J.; Smeets, J.; Vander Stappen, F.; Bombelli, L.; Fiorini, C.; Hotoiu, L.; Perali, I.; Prieels, D.; Enghardt, W.; Baumann, M.

PET in the management of locally advanced and metastatic NSCLC
Grootjans, W.; de Geus-Oei, L.-F.; Troost, E. G. C.; Visser, E. P.; Oyen, W. J. G.; Bussink, J.

Imaging-Based Treatment Adaptation in Radiation Oncology
Troost, E. G.; Thorwarth, D.; Oyen, W. J.

Radiotherapy combined with the immunocytokine L19-IL2 provides long-lasting antitumor effects.
Zegers, C. M.; Rekers, N. H.; Quaden, D. H.; Lieuwes, N. G.; Yaromina, A.; Germeraad, W. T.; Wieten, L.; Biessen, E. A.; Boon, L.; Neri, D.; Troost, E. G.; Dubois, L. J.; Lambin, P.

A teaching intervention in a contouring dummy run improved target volume delineation in locally advanced non-small cell lung cancer: Reducing the interobserver variability in multicentre clinical studies.
Schimek-Jasch, T.; Troost, E. G.; Rücker, G.; Prokic, V.; Avlar, M.; Duncker-Rohr, V.; Mix, M.; Doll, C.; Grosu, A. L.; Nestle, U.

The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis.
Leijenaar, R. T.; Nalbantov, G.; Carvalho, S.; van Elmpt, W. J.; Troost, E. G.; Boellaard, R.; Aerts, H. J.; Gillies, R. J.; Lambin, P.

Is integrated transit planar portal dosimetry able to detect geometric changes in lung cancer patients treated with volumetric modulated arc therapy?
Persoon, L. C.; Podesta, M.; Hoffmann, L.; Sanizadeh, A.; Schyns, L. E.; de Ruiter, B. M.; Nijsten, S. M.; Muren, L. P.; Troost, E. G.; Verhaegen, F.

Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion.
van Elmpt, W.; Zegers, C. M. L.; Reymen, B.; Even, A. J. G.; Dingemans, A.-M.; Oellers, M.; Wildberger, J. E.; Mottaghy, F. M.; Das, M.; Troost, E. G. C.; Lambin, P.

Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.
Hendriks, L. E.; Derks, J. L.; Postmus, P. E.; Damhuis, R. A.; Houben, R. M.; Troost, E. G.; Hochstenbag, M. M.; Smit, E. F.; Dingemans, A. M.

Increasing the Therapeutic Ratio of Stereotactic Ablative Radiotherapy by Individualized Isotoxic Dose Prescription
Zindler, J. D.; Thomas, C. R.; Hahn, S. M.; Hoffmann, A. L.; Troost, E. G. C.; Lambin, P.

Requirements for a Compton camera for in-vivo range verification of proton therapy
Rohling, H.; Priegnitz, M.; Schöne, S.; Schumann, A.; Enghardt, W.; Hueso-Gonzalez, F.; Pausch, G.; Fiedler, F.

From prompt gamma distribution to dose: A novel approach combining an evolutionary algorithm and filtering based on gaussian-powerlaw convolutions
Schumann, A.; Priegnitz, M.; Schoene, S.; Enghardt, W.; Rohling, H.; Fiedler, F.

Advances in radiotherapy special feature.
Krause, M.; Supiot, S.

Comparison of [18F]-FMISO, [18F]-FAZA and [18F]-HX4 for PET imaging of hypoxia - a simulation study.
Wack, L. J.; Mönnich, D.; van Elmpt, W.; Zegers, C. M.; Troost, E. G.; Zips, D.; Thorwarth, D.

Valproic acid modulates radiation-enhanced matrix metalloproteinase activity and invasion of breast cancer cells.
Artacho-Cordón, F.; Ríos-Arrabal, S.; Olivares-Urbano, M. A.; Storch, K.; Dickreuter, E.; Muñoz-Gámez, J. A.; León, J.; Calvente, I.; Torné, P.; Salinas, M. D.; Cordes, N.; Núñez, M. I.

ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation.
Hausmann, C.; Temme, A.; Cordes, N.; Eke, I.

Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure
Zschaeck, S.; Haase, R.; Abolmaali, N.; Perrin, R.; Stützer, K.; Appold, S.; Steinbach, J.; Kotzerke, J.; Zips, D.; Richter, C.; Gudziol, V.; Krause, M.; Zöphel, K.; Baumann, M.

Prognostic Value of Pretherapeutic Tumor-to-Blood Standardized Uptake Ratio in Patients with Esophageal Carcinoma
Bütof, R.; Hofheinz, F.; Zöphel, K.; Stadelmann, T.; Schmollack, J.; Jentsch, C.; Loeck, S.; Kotzerke, J.; Baumann, M.; van den Hoff, J.

Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs.
von Neubeck, C.; Seidlitz, A.; Kitzler, H. H.; Beuthien-Baumann, B.; Krause, M.

Radiation therapy and the global health agenda
Jaffray, D. A.; Atun, R.; Barton, M.; Baumann, M.; Gospodarowicz, M.; Hoskin, P.; Knaul, F. M.; Lievens, Y.; Rosenblatt, E.; Torode, J.; van Dyk, J.; Vikram, B.; Union for International Cancer Control'S Global Task Force On Radiotherapy For Cancer Control

γH2AX assay in ex vivo irradiated tumour specimens: A novel method to determine tumour radiation sensitivity in patient-derived material.
Menegakis, A.; von Neubeck, C.; Yaromina, A.; Thames, H.; Hering, S.; Hennenlotter, J.; Scharpf, M.; Noell, S.; Krause, M.; Zips, D.; Baumann, M.

Pages: [All] [1] [2]